317 related articles for article (PubMed ID: 21824099)
1. Medicinal chemistry perspectives of trioxanes and tetraoxanes.
Kumar N; Sharma M; Rawat DS
Curr Med Chem; 2011; 18(25):3889-928. PubMed ID: 21824099
[TBL] [Abstract][Full Text] [Related]
2. Tetraoxanes: synthetic and medicinal chemistry perspective.
Kumar N; Singh R; Rawat DS
Med Res Rev; 2012 May; 32(3):581-610. PubMed ID: 22675731
[TBL] [Abstract][Full Text] [Related]
3. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
4. An overview on the antimalarial activity of 1,2,4-trioxanes, 1,2,4-trioxolanes and 1,2,4,5-tetraoxanes.
Shukla M; Rathi K; Hassam M; Yadav DK; Karnatak M; Rawat V; Verma VP
Med Res Rev; 2024 Jan; 44(1):66-137. PubMed ID: 37222435
[TBL] [Abstract][Full Text] [Related]
5. Tetraoxanes as antimalarials: harnessing the endoperoxide.
Fisher LC; Blackie MA
Mini Rev Med Chem; 2014 Feb; 14(2):123-35. PubMed ID: 24456270
[TBL] [Abstract][Full Text] [Related]
6. An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity.
Ellis GL; Amewu R; Hall C; Rimmer K; Ward SA; O'Neill PM
Bioorg Med Chem Lett; 2008 Mar; 18(5):1720-4. PubMed ID: 18243702
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.
O'Neill PM; Amewu RK; Nixon GL; Bousejra ElGarah F; Mungthin M; Chadwick J; Shone AE; Vivas L; Lander H; Barton V; Muangnoicharoen S; Bray PG; Davies J; Park BK; Wittlin S; Brun R; Preschel M; Zhang K; Ward SA
Angew Chem Int Ed Engl; 2010 Aug; 49(33):5693-7. PubMed ID: 20629058
[No Abstract] [Full Text] [Related]
8. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
9. Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Wang X; Dong Y; Wittlin S; Charman SA; Chiu FC; Chollet J; Katneni K; Mannila J; Morizzi J; Ryan E; Scheurer C; Steuten J; Santo Tomas J; Snyder C; Vennerstrom JL
J Med Chem; 2013 Mar; 56(6):2547-55. PubMed ID: 23489135
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of the antimalarial, anticancer, and caspase 3 activities of tetraoxane dimers.
Amewu RK; Chadwick J; Hussain A; Panda S; Rinki R; Janneh O; Ward SA; Miguel C; Burrell-Saward H; Vivas L; O'Neill PM
Bioorg Med Chem; 2013 Dec; 21(23):7392-7. PubMed ID: 24148834
[TBL] [Abstract][Full Text] [Related]
11. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
Patel OPS; Beteck RM; Legoabe LJ
Eur J Med Chem; 2021 Mar; 213():113193. PubMed ID: 33508479
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges.
Tiwari MK; Chaudhary S
Med Res Rev; 2020 Jul; 40(4):1220-1275. PubMed ID: 31930540
[TBL] [Abstract][Full Text] [Related]
13. Tetraoxanes: synthetic and medicinal chemistry perspective.
Kumar N; Singh R; Rawat DS
Med Res Rev; 2010 Nov; ():. PubMed ID: 21064188
[TBL] [Abstract][Full Text] [Related]
14. Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs.
Ploypradith P
Acta Trop; 2004 Feb; 89(3):329-42. PubMed ID: 14744559
[TBL] [Abstract][Full Text] [Related]
15. A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.
Grigorov M; Weber J; Tronchet JM; Jefford CW; Milhous WK; Maric D
J Chem Inf Comput Sci; 1997; 37(1):124-30. PubMed ID: 9025258
[TBL] [Abstract][Full Text] [Related]
16. Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid.
Kumura N; Furukawa H; Onyango AN; Izumi M; Nakajima S; Ito H; Hatano T; Kim HS; Wataya Y; Baba N
Chem Phys Lipids; 2009 Aug; 160(2):114-20. PubMed ID: 19426722
[TBL] [Abstract][Full Text] [Related]
17. [Review of the use of artemisinin and its derivatives in the treatment of malaria].
Van der Meersch H
J Pharm Belg; 2005; 60(1):23-9. PubMed ID: 15828489
[TBL] [Abstract][Full Text] [Related]
18. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
19. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.
O'Neill PM; Amewu RK; Charman SA; Sabbani S; Gnädig NF; Straimer J; Fidock DA; Shore ER; Roberts NL; Wong MH; Hong WD; Pidathala C; Riley C; Murphy B; Aljayyoussi G; Gamo FJ; Sanz L; Rodrigues J; Cortes CG; Herreros E; Angulo-Barturén I; Jiménez-Díaz MB; Bazaga SF; Martínez-Martínez MS; Campo B; Sharma R; Ryan E; Shackleford DM; Campbell S; Smith DA; Wirjanata G; Noviyanti R; Price RN; Marfurt J; Palmer MJ; Copple IM; Mercer AE; Ruecker A; Delves MJ; Sinden RE; Siegl P; Davies J; Rochford R; Kocken CHM; Zeeman AM; Nixon GL; Biagini GA; Ward SA
Nat Commun; 2017 May; 8():15159. PubMed ID: 28537265
[TBL] [Abstract][Full Text] [Related]
20. Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy.
Tiwari MK; Yadav DK; Chaudhary S
Curr Top Med Chem; 2019; 19(10):831-846. PubMed ID: 30977453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
